Epithelioid Haemangioendothelioma Observational Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione IRCCS Istituto Nazionale dei Tumori, Milano
About this trial
The EHE observational study was developed to obtain a high number of datas such as clinical presentation, natural history, and treatment outcomes, cto identificate cytokines and hormones as biomarkers and generate patient-derived preclinical models as a tool to assess the activity of anticancer agents and validate novel therapeutic targets
Eligibility criteria
Qualifiers
Histological diagnosis of EHE according to 2020 WHO classification, performed on biopsy or surgical specimen
Signed informed consent
Adequate patient compliance to treatment or follow up
No age limit
Disqualifiers
Impossibility to ensure adequate compliance
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 5 trial groupsSponsors and collaborators
Source ClinicalTrials.gov